Abvance Therapeutics
Manufacturing · 1-10 Employees
View Company Info for Free
Overview
Website
www.abvancetherapeutics.comRevenue
<$5 MillionIndustry
About Abvance Therapeutics
Abvance Therapeutics Org Chart
Chief Operating Officer
Is Abvance Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Abvance Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Abvance Therapeutics recently announced quarterly report
Check out if Abvance Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Abvance Therapeutics has new funding data
Click to see if Abvance Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Abvance Therapeutics
Abvance Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Abvance Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Abvance Therapeutics
Compare insights from companies similar to Abvance Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Abvance Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Abvance Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Abvance Therapeutics.
Abvance Therapeutics Tech Stack
A closer look at the technologies used by Abvance Therapeutics
Most Recent Scoops
Abvance Therapeutics News & Media
Abvance Therapeutics Announces Presentation of Human Clinical Data at the 85th Scientific Sessions of the American Diabetes Association
Abvance presents first-in-human data on insulin-glucagon co-dosing in T1D, demonstrating a novel approach to help prevent hypoglycemiaAbvance Therapeutics Announces $3.9M Program Related Investment from the Helmsley Charitable Trust to Support Development of Its Novel Insulin and Glucagon Combined Formulation
NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Abvance Therapeutics (“Abvance” or “The Company”), a development stage biopharmaceutical company founded on breakthrough discoveries from the Vanderbilt University Cherrington Lab, today announced that it has secured a $3.9 million Program Related Investment in the form of a loan from The Leona M. and Harry B. Helmsley Charitable Trust. The funding is non-dilutive and will support the pre-clinical development of ABV100, the Company’s initial proprieta
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Abvance Therapeutics
Abvance Therapeutics, Inc. is a privately held biotechnology company advancing novel glucagon-based therapies designed to integrate into the lived experience of diabetes care.... Read More
